Melanocyte proliferation may be desired in a variety of pathological conditions. Melanocytes are important, for example in burn patients where it is desireble to obtain a sufficient layer of skin so as to avoid scepticemia. Melanocytic proliferation is demonstrated in this patent by treatment with stem cell factor (kit-ligand), as well as combinations of stem cell factor with other cytokines.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.